https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
The Big News Driving the Surge NeurAxis dropped a bombshell this morning, announcing that its IB-Stim device has received FDA 510(k) clearance for treating functional abdominal pain associated with functional dyspepsia and related nausea in kids aged 8 to 21. This isn’t just another regulatory checkbox—this is the first FDA-approved treatment for functional dyspepsia in … Read more
In today’s fast-paced biotech landscape, it takes more than just innovative technology to make waves – it also requires significant market momentum. And that’s exactly what NeOnc Technologies Holdings (NTHI), a new IPO on the NASDAQ Global Market, has achieved with its recent Rare Pediatric Disease Designation for NEO100. This designation is a game-changer for … Read more
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal InformationFORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4